Did you know that after possibly knowing for years, the US Food and Drug Administration (FDA) is only know getting around to mandating a black box warning for Reglan side effects (Reglan tardive dyskinesia)? Metoclopramide side effects can be either temporary, or permanent. It can have life-altering effects on a patient's health and well-being...
Did you know that after possibly knowing for years, the US Food and Drug Administration (FDA) is only know getting around to mandating a black box warning for Reglan side effects (Reglan tardive dyskinesia)? Metoclopramide side effects can be either temporary, or permanent. It can have life-altering effects on a patient's health and well-being...
Researchers from the Mayo Clinic College of Medicine, in their quest to come out with a drug to curb the 'diabetes epidemic' have developed a medication tailored after a hormone released by Gila monster lizards. The synthetic form of the hormone is called exenatide (Byetta). Animal studies show that exenatide is effective in controlling blood sugar, helps the pancreas regrow insulin-producing cells, and might be the only drug to actually reverse the disease itself, reports from the research at the Mayo Clinic College of Medicine said...
In what appears to be an epidemic amongst drug manufacturers, the US Food and Drug Administration (FDA) has taken Avandia maker GlaxoSmithKline to task for withholding information about the drug long suspected of harboring a higher risk of heart attack than patients on other diabetes drugs. A stern warning letter was forwarded to Glaxo on March 25th, and posted to the FDA web site one week ago...
In what appears to be an epidemic amongst drug manufacturers, the US Food and Drug Administration (FDA) has taken Avandia maker GlaxoSmithKline to task for withholding information about the drug long suspected of harboring a higher risk of heart attack than patients on other diabetes drugs. A stern warning letter was forwarded to Glaxo on March 25th, and posted to the FDA web site one week ago...
In what appears to be an epidemic amongst drug manufacturers, the US Food and Drug Administration (FDA) has taken Avandia maker GlaxoSmithKline to task for withholding information about the drug long suspected of harboring a higher risk of heart attack than patients on other diabetes drugs. A stern warning letter was forwarded to Glaxo on March 25th, and posted to the FDA web site one week ago...
When a drug is vilified as much as diabetes drug Avandia has for the risk of heart attack, one could understand the zeal with which a manufacturer approaches any piece of seemingly good news. This most recent carrot came in the form of a small study, which appears to suggest that Avandia can slow the progression of atherosclerosis in diabetic patients who have undergone cardiac bypass surgery...
When a drug is vilified as much as diabetes drug Avandia has for the risk of heart attack, one could understand the zeal with which a manufacturer approaches any piece of seemingly good news. This most recent carrot came in the form of a small study, which appears to suggest that Avandia can slow the progression of atherosclerosis in diabetic patients who have undergone cardiac bypass surgery...
